Naviswiss is a leading brand in the field of smart-assisted surgery, dedicated to improving surgical outcomes and benefiting patients and the healthcare system. With a strong focus on ease of use in the surgical workflow, Naviswiss has become known for its innovative mindset in joint replacement surgery. The company has a timeline of success, starting with exploratory research and development in 2015, followed by meticulous technology refinement in 2017.

In 2018, Naviswiss achieved clinical validation and regulatory clearance for Japan, Australia, and the EU. Subsequently, in 2019, the brand began its initial commercialization in Japan, Australia, and selected EU markets. The year 2020 marked an important milestone with FDA clearance for Naviswiss Hip, leading to the ramp-up of their direct sales organization in the US.

In 2021, both Naviplan and Naviswiss Hip CT received FDA clearance. Naviswiss boasts a dedicated team of engineers, marketing specialists, and regulatory experts, ensuring continuous innovation and a successful global product launch. The management team includes industry experts like CEO Jan Stifter, with extensive experience in computer-assisted surgery, and Head of Sales and Marketing Christian Calame, who brings over 30 years of experience in the biomedical industry.

Together, the team at Naviswiss is committed to revolutionizing surgical navigation and improving patient outcomes, making them a trusted brand in the field